Androgen receptor: a potential therapeutic target for glioblastoma

The median survival time of patients with glioblastoma is still poor (14.6 month), partly due to a lack of effective treatment. We have observed that androgen receptor (AR) is amplified in glioblastomas at the DNA, RNA and protein levels. The AR gene was amplified in 27% of glioblastoma specimens fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zalcman, Nomi, Canello, Tamar, Ovadia, Haim, Charbit, Hanna, Zelikovitch, Bracha, Mordechai, Anat, Fellig, Yakov, Rabani, Stav, Shahar, Tal, Lossos, Alexander, Lavon, Iris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929440/
https://www.ncbi.nlm.nih.gov/pubmed/29731997
http://dx.doi.org/10.18632/oncotarget.25007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929440/
https://www.ncbi.nlm.nih.gov/pubmed/29731997
http://dx.doi.org/10.18632/oncotarget.25007

Ejemplares similares